Frank Clyburn serves as Chief Executive Officer of IFF.
Clyburn was most recently the Executive Vice President and President of Human Health for Merck, where he had full P&L responsibility of Merck’s largest business. During his time at Merck, he was also responsible for building one of the leading oncology business in the world which is now transforming cancer care and is the largest business within Merck.
Clyburn was an integral part of the integration of Merck’s $41 billion acquisition of Schering-Plough, where the company achieved strong top-line growth and delivered significant cost synergies.
Prior to his most recent role, Clyburn was Chief Commercial Officer for Merck, responsible for Human Health commercial operations and the Human Health P&L. From 2013 to 2018, he was the inaugural president of the company’s Global Oncology business.
Clyburn currently serves on the Board of Directors for the European Federation of Pharmaceutical Industries and Associations (EFPIA). He also served as chairman to the Thomas Edison State University Board of Trustees.
Clyburn received his MBA degree from Arizona State University and his Bachelor of Arts degree from Franklin & Marshall College.
